Found: 17
Select item for more details and to access through your institution.
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 8, p. 1676, doi. 10.3390/pharmaceutics14081676
- By:
- Publication type:
- Article
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 393, doi. 10.1111/bjh.17654
- By:
- Publication type:
- Article
Nilotinib after imatinib first‐line: a real‐life longitudinal cohort of patients with chronic myeloid leukaemia in chronic phase.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 3, p. 356, doi. 10.1111/bjh.15042
- By:
- Publication type:
- Article
Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 1, p. 71, doi. 10.1111/bjh.14022
- By:
- Publication type:
- Article
High frequency of cutaneous eruptions within the first year after allogeneic hematopoietic stem cell transplantation.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 456, doi. 10.1002/jvc2.125
- By:
- Publication type:
- Article
Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 9, p. 1007, doi. 10.1177/10600280211068177
- By:
- Publication type:
- Article
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1321, doi. 10.1007/s00277-022-04821-y
- By:
- Publication type:
- Article
Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 4, p. 399, doi. 10.1111/ejh.12752
- By:
- Publication type:
- Article
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 6, p. 503, doi. 10.1111/j.1600-0609.2008.01060.x
- By:
- Publication type:
- Article
Risk factors for candidemia: a prospective matched case-control study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Graft-versus-host disease-related neuropathy: AMAN phenotype with improvement after plasmapheresis.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 10, p. 711, doi. 10.1007/s00277-006-0152-y
- By:
- Publication type:
- Article
Diagnostic et gestion des effets secondaires pleuropulmonaires des inhibiteurs de tyrosine kinase Recommandations du Groupe français pour la leucémie myéloïde chronique.
- Published in:
- Hematologie, 2018, v. 24, n. 2, p. 134, doi. 10.1684/hma.2018.1362
- By:
- Publication type:
- Article
Hématologie, soins palliatifs et sciences humaines : une rencontre réflexive qui déplace les représentations.
- Published in:
- Hematologie, 2017, v. 23, n. 2, p. 144, doi. 10.1684/hma.2017.1258
- By:
- Publication type:
- Article
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
- Published in:
- Fundamental & Clinical Pharmacology, 2021, v. 35, n. 2, p. 435, doi. 10.1111/fcp.12593
- By:
- Publication type:
- Article